A 32-year-old woman is diagnosed with systemic lupus erythematosus based on clinical and serological criteria. Which of the following is the most common autoantibody found in SLE?

Question

Accepted Answer

C. Anti-dsDNA (anti-double-stranded DNA) antibodies. ## Autoantibodies in Systemic Lupus Erythematosus

**Key Point:** Anti-dsDNA (anti-double-stranded DNA) antibodies are the most common autoantibodies in SLE, present in 60–70% of SLE patients, and are highly specific for SLE diagnosis.

### Prevalence and Specificity of SLE Autoantibodies

| Autoantibody | Prevalence in SLE | Specificity for SLE | Clinical Significance |
|--------------|-------------------|-------------------|----------------------|
| **Anti-dsDNA** | **60–70%** | **Very high (95–98%)** | **Lupus nephritis, disease activity** |
| ANA (any pattern) | 95–98% | Low (present in many conditions) | Screening test, high sensitivity |
| Anti-Sm | 20–30% | Very high (99%) | Diagnostic criterion, rare in other diseases |
| Anti-histone | 50–60% | Moderate (drug-induced lupus) | Drug-induced SLE, less specific |
| Anti-centromere | 5–10% | Moderate (also in scleroderma) | Limited SLE association |
| Anti-Ro/SSA | 40–60% | Moderate (also in Sjögren's) | Neonatal lupus, photosensitivity |
| Anti-La/SSB | 20–40% | High (Sjögren's association) | Sjögren's overlap |

**High-Yield:** Although anti-Sm is more specific (99%) for SLE, anti-dsDNA is more common (60–70% vs. 20–30%), making it the **most common** autoantibody.

### Clinical Correlations

**Clinical Pearl:** Anti-dsDNA antibodies correlate with:
- **Lupus nephritis:** Presence of anti-dsDNA strongly predicts renal involvement
- **Disease activity:** Titers fluctuate with disease flares; rising titers often precede clinical exacerbation
- **Complement consumption:** High anti-dsDNA often accompanies low C3 and C4 levels
- **Serositis and vasculitis:** Associated with systemic manifestations

### Pathogenic Mechanism

Anti-dsDNA antibodies:
1. Form immune complexes with circulating dsDNA
2. Deposit in glomerular basement membrane and other tissues
3. Activate complement (classical pathway)
4. Trigger inflammation via Fc receptor engagement
5. Cross-react with nucleosomal antigens and glomerular components

**Warning:** Do not confuse anti-dsDNA with anti-ssDNA (single-stranded DNA). Anti-ssDNA is less specific and less clinically significant.

### SLE Diagnostic Criteria Integration

Anti-dsDNA positivity is one of the **EULAR/ACR 2019 classification criteria** for SLE:
- Anti-dsDNA (or anti-Sm) antibodies at medium or high titer = 6 points (sufficient for SLE diagnosis if combined with other criteria)

**Mnemonic: "dsDNA = Disease Specific DNA"**
- **d** = Double-stranded (more specific than single-stranded)
- **s** = Specific for SLE (95–98% specificity)
- **DNA** = Diagnostic marker for lupus nephritis and disease activity

### Why Not the Other Options?

**Anti-Sm antibodies:**
- More specific (99%) but less common (20–30%)
- Rarely found outside SLE
- Diagnostic but not the most frequent

**Anti-histone antibodies:**
- Common in drug-induced lupus (>95%)
- Present in 50–60% of idiopathic SLE
- Less specific than anti-dsDNA
- Associated with milder disease

**Anti-centromere antibodies:**
- Rare in SLE (5–10%)
- More common in limited cutaneous systemic sclerosis (LCSS)
- Not a primary SLE marker

Answer

A. Anti-histone antibodies

Answer

B. Anti-Smith (anti-Sm) antibodies

Answer

D. Anti-centromere antibodies

A 32-year-old woman is diagnosed with systemic lupus erythematosus based on clinical and serological criteria. Which of the following is the most common autoantibody found in SLE?

Explanation

Autoantibodies in Systemic Lupus Erythematosus

Prevalence and Specificity of SLE Autoantibodies

Clinical Correlations

Pathogenic Mechanism

SLE Diagnostic Criteria Integration

Why Not the Other Options?

Practice similar questions

Join our NEET PG community

Autoantibody	Prevalence in SLE	Specificity for SLE	Clinical Significance
Anti-dsDNA	60–70%	Very high (95–98%)	Lupus nephritis, disease activity
ANA (any pattern)	95–98%	Low (present in many conditions)	Screening test, high sensitivity
Anti-Sm	20–30%	Very high (99%)	Diagnostic criterion, rare in other diseases
Anti-histone	50–60%	Moderate (drug-induced lupus)	Drug-induced SLE, less specific
Anti-centromere	5–10%	Moderate (also in scleroderma)	Limited SLE association
Anti-Ro/SSA	40–60%	Moderate (also in Sjögren's)	Neonatal lupus, photosensitivity
Anti-La/SSB	20–40%	High (Sjögren's association)	Sjögren's overlap